Victorian Comprehensive Cancer Centre

Victorian Comprehensive Cancer Centre

The Victorian Comprehensive Cancer Centre (VCCC) is an alliance of 10 leading research, academic and clinical institutions working together to accelerate and amplify leading-edge cancer research, knowledge and expertise to benefit patients in Victoria. 

About the VCCC

Ten leading Melbourne-based organisations have come together to form the VCCC, a centre of excellence aimed at saving lives through an integrated approach to cancer prevention, detection and treatment.

Member organisations:

“The VCCC is more than a building: it achieves a long-held desire of the entire Melbourne biomedical research community to create Australia’s largest purpose-built centre for cancer research, treatment and care” – Professor Doug Hilton

The VCCC facility is located in the Parkville health precinct, close to the Walter and Eliza Hall Institute’s Parkville campus.

Our contribution to the VCCC

The Institute’s involvement in the VCCC is driven by our research focus and underpinned by a strong track record of cancer drug development. Our discoveries in cancer have improved the lives of millions of cancer patients worldwide.

As the research powerhouse of the collaboration, the Institute is home to more cancer researchers than any other VCCC member organisation, and includes leading clinician researchers in blood, breast, ovarian and bowel cancer who are providing their expertise to the group.

The Institute’s successful model for translating discoveries into clinical outcomes benefits for patients is now also being employed by the VCCC.

Advantages to VCCC collaboration

The most effective way to translate our discoveries into benefits for cancer patients is through collaboration.

With access to a wider network of hospitals and diagnostic technologies through the VCCC, we can accelerate the process of seeing our laboratory discoveries being translated into tangible benefits for people with cancer.

Through innovation and collaboration, the VCCC and its membership will drive the next generation of improvement in the prevention, detection and treatment of cancer.

Colony stimulating factors - WEHI.TV animation

Since their discovery by Professor Donald Metcalf and his colleagues, CSFs have helped millions of cancer patients to survive the damage to bone marrow caused by high-dose chemotherapy.